Gary Jacob

Gary S.
Jacob founded Synergy Pharmaceuticals, Inc. in 2008, where he worked as Chairman, President & Chief Executive Officer from 2013 to 2017.
Dr. Jacob also founded Synergy Pharmaceuticals LLC, where he worked as Executive Chairman from 2017 to 2018.
Dr. Jacob also currently works at OKYO Pharma Ltd., as Chief Executive Officer & Executive Director from 2021 and Actavia Life Sciences, Inc., as Independent Director from 2020.
Dr. Jacob also formerly worked at Callisto Pharmaceuticals, Inc., as President, Chief Executive Officer & Director from 2004 to 2013, Pawfect Foods, Inc., as President, Chief Executive Officer & Director in 2008, Immuron Ltd., as CEO, Non-Executive Director & Managing Director from 2019 to 2020, Hepion Pharmaceuticals, Inc., as Chairman from 2014 to 2024, Synergy DE, as Chairman in 2008, Monsanto Co., as Director-Functional Genomics, Science & Technology from 1997 to 1998, Cardiff Oncology, Inc., as Independent Director from 2012 to 2021, G.D.
Searle LLC, as Glycobiology Director from 1990 to 1997, Virpax Pharmaceuticals, Inc., as Independent Director from 2020 to 2022, and the University of Oxford, as Manager-Searle Glycobiology Group in 1990.
Dr. Jacob received his doctorate degree from the University of Wisconsin and undergraduate degree from the University of Missouri-St. Louis.